Article Information
History
- July 12, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Quan Xu1,2,#,
- Yueyue Liu1,#,
- Dawei Sun1,2,#,
- Xiaoqian Huang1,
- Feihong Li1,
- JinCheng Zhai1,
- Yang Li3,
- Qiming Zhou1,2,* and
- Beifang Niu2,4,5,*
- 1Beijing ChosenMed Clinical Laboratory Co. Ltd., Jinghai Industrial Park, Economic and Technological Development Area, Beijing, 100176, China
- 2ChosenMed Technology (Zhejiang) Co. Ltd., Hangzhou, China
- 3Chongqing Research Institute of Big Data, Peking University, Chongqing, China
- 4Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China
- 5University of Chinese Academy of Sciences, Beijing 100190, China
- ↵*To whom correspondence should be addressed: Beifang Niu, Ph.D, ChosenMed Technology (Zhejiang) Co. Ltd., Hangzhou, China; Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100190, China., Tel: +86-010-58812132, Fax: +86-010-56380035, Email: niubf{at}cnic.cn, Correspondence may also be addressed to:, Qiming Zhou, Ph.D, Beijing ChosenMed Clinical Laboratory Co. Ltd., Jinghai Industrial Park, Economic and Technological Development Area, Beijing, 100176, China; ChosenMed Technology (Zhejiang) Co. Ltd., Hangzhou, China., Tel: +86-010-56380035, Fax: +86-010-56380035, E-mail: qimingzhou{at}chosenmedtech.com
↵# These authors contributed equally.
Posted July 12, 2023.
OncoCTMiner: streamlining precision oncology trial matching via molecular profile analysis
